$VGNT

CLARK KEVIN P sold $4.3M of VGNT

CLARK KEVIN P sold 97,278 shares of Versigent PLC (VGNT) at an average of $44.69 ($44.33–$46.43, $4.35M total) across 5 trades over 2026-10-07 to 2026-10-08 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · CLARK KEVIN P
Published Oct 9, 2026, 8:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 8:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VGNT
Bearish
medium confidence
Mentioned
$VGNT
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VGNTBearishLow
01

Why it matters

The disclosed sale reduces insider ownership and may be interpreted as a bearish signal, though the amount is modest.

02

Market read

Primary source insider sale; modest relevance for short‑term traders monitoring insider activity.

03

What to watch

Potential upcoming corporate actions or financing needs that prompted the insider to free cash.

Relevance 5/10Novelty 5/10Timing: today (filed Oct 9)

Background

SEC Form 4 filings disclose insider transactions; a director’s sale via a 10b5‑1 plan is a routine but material event for small caps.

Company-level read

Ticker impact

$VGNTBearishMedium confidence
Context

Director Kevin Clark sold 97,278 shares for $4.35M via a 10b5‑1 plan, reducing his stake to 27,571 shares.

Expected impact

likely slight pressure as the market prices in the insider sell

Evidence & confidence

A $4.3M sale by a director using a pre‑arranged plan is material for a micro‑cap, but the amount is modest relative to market cap.

Market effects

Minimal; the sale is company‑specific and does not affect the broader sector.

None; the filing is a standard SEC disclosure.

Low; only relevant to investors in VGNT.

Counterpoint

The sale could be purely liquidity‑driven and not reflect negative outlook, so the stock may remain stable.

Key entities

  • Versigent PLC

    Issuer of the Form 4 filing, ticker VGNT.

  • Kevin Clark

    Director of Versigent PLC who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

High

Why Versigent Is Dropping 6.1%: Goldman Sachs Maintains Buy

Versigent PLC shares fell 6.1% to $44.50 after Goldman Sachs reduced its price target from $59 to $58, citing a cautious near-term outlook. The firm maintained a Buy rating, suggesting long-term confidence. Trading volume surged to 295,421 shares, reflecting heightened selling pressure. Investors reacted strongly to the modest target cut, potentially indicating broader sector concerns.

$VGNTMedAI 8/10

Versigent Q2 Earnings Call Highlights

Versigent (NYSE:VGNT) reported Q2 net income growth despite $35M incremental interest expense from 1Q 2026 debt financing. Adjusted tax rate rose to 27% from 16% year ago. Sales grew in Asia-Pacific and Americas, fell in EMEA. Copper costs pressured margins, but pass-through recoveries eased. 2026 net sales guidance raised to $9.4B-$9.6B; dividend $0.13 declared.

$VGNTHigh

Versigent Reports Second Quarter 2026 Results

Versigent PLC (VGNT) filed an SEC Form 8-K — Results of Operations and Financial Condition. PRESS RELEASE Versigent Reports Second Quarter 2026 Results Delivers 11% Net Sales Growth; Raises and Tightens Full-Year 2026 Net Sales Guidance; Initiates Quarterly Dividend SCHAFFHAUSEN, Switzerland, August 4, 2026 – Versigent PLC (NYSE: VGNT), a global leader in the design and